Kolexia
Launay Vincent
Hématologie
Centre Hospitalier de Saint Brieuc
Saint-Brieuc, France
48 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Leucémies Lymphome B diffus à grandes cellules Lymphome folliculaire Lymphome B Leucémie myéloïde chronique BCR-ABL positive Leucémie myéloïde Cataracte Insuffisance ovarienne primitive

Industries

Janssen
22 collaboration(s)
Dernière en 2023
Takeda Pharmaceutical
7 collaboration(s)
Dernière en 2023
AstraZeneca
6 collaboration(s)
Dernière en 2023
Amgen
5 collaboration(s)
Dernière en 2023

Dernières activités

Challenges for quality and utilization of real-world data for diffuse large B-cell lymphoma in REALYSA, a LYSA cohort.
Blood advances   24 octobre 2023
Quality of life and response shift effect of diffuse large B-cell lymphoma French patients included in prospective real-life REALYSA cohort in the first year after diagnosis
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 ‐ 17 June, 2023   09 juin 2023
Randomized Phase III Trial Evaluating Subcutaneous Rituximab for the First-Line Treatment of Low-Tumor Burden Follicular Lymphoma: Results of a LYSA Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology   18 avril 2023
FLIRT: A Randomized Phase III Trial Evaluating Two Strategies of Rituximab Administration for the Treatment of First Line/Low Tumor Burden Follicular Lymphoma (Follicular Lymphoma IV/SC Rituximab Therapy)
Essai Clinique (Roche)   09 janvier 2023
Premature Ovarian Insufficiency in CLPB Deficiency: Transcriptomic, Proteomic and Phenotypic Insights.
The Journal of clinical endocrinology and metabolism   28 novembre 2022
Functional characterization of PD1+TIM3+ tumor-infiltrating T cells in DLBCL and effects of PD1 or TIM3 blockade.
Blood advances   31 mai 2021
Integrative Analysis of Cell Crosstalk within Follicular Lymphoma Cell Niche: Towards a Definition of the FL Supportive Synapse.
Cancers   05 octobre 2020
Switches of tyrosine-kinase inhibitors in chronic phase of chronic myeloid leukemia in real life.
American journal of hematology   30 septembre 2018
Medico-economic benefits of subcutaneous formulations of trastuzumab and rituximab in day hospitalisation (SCuBA Study).
Bulletin du cancer   21 septembre 2018
segment utilization in immunoglobulin gene rearrangement differentiates patients with anti-myelin-associated glycoprotein neuropathy from others immunoglobulin M-gammopathies.
Haematologica   25 janvier 2018